Drug Search Results
More Filters [+]

Penbutolol

Alternative Names: penbutolol, levatol
Latest Update: 2024-04-09
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRB1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Germany | Ireland | Italy | New Zealand | Portugal | Taiwan | Turkey

Approved Indications: None

Known Adverse Events: None

Company: Weill Medical College of Cornell University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Penbutolol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title